SFRP2 methylation in fecal DNA - A marker for colorectal polyps

International Journal of Colorectal Disease

Volumn 23, Issue 1, 2008, Pages 15-19

  Oberwalder, Michael ^a   Zitt, Marion ^a   Wöntner, Cornelia ^a   Fiegl, Heidi ^b   Goebel, Georg ^a   Zitt, Matthias ^b   Köhle, Olivia ^a   Mühlmann, Gilbert ^a   Öfner, Dietmar ^a   Margreiter, Raimund ^b   Müller, Hannes M ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b TYROLEAN CANCER RESEARCH INSTITUTE   (Austria)

Author keywords

Colorectal polyps; DNA methylation; Fecal DNA; MethyLight; SFRP2; Stool

Indexed keywords

DNA; FRIZZLED PROTEIN; PROTEIN SFRP2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COLON POLYPOSIS; COLONOSCOPY; COLORECTAL ADENOMA; CONTROLLED STUDY; DISEASE MARKER; DNA CONTENT; DNA ISOLATION; DNA METHYLATION; FECES ANALYSIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADENOMATOUS POLYPS; ADULT; AGED; CASE-CONTROL STUDIES; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; DNA; DNA METHYLATION; FECES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 36349001733     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-007-0355-2     Document Type: Article

References (30)

1. Jass JR, Whitehall VL, Young J, Leggett BA (2002) Emerging concepts in colorectal neoplasia. Gastroenterology 123:862-876
2. Kozuka S, Nogaki M, Ozeki T, Masumori S (1975) Premalignancy of the mucosal polyp in the large intestine: II. Estimation of the periods required for malignant transformation of mucosal polyps. Dis Colon Rectum 18:494-500
3. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767
4. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159-170
5. Morson BC (1974) Evolution of cancer of the colon and rectum. Cancer 34(Suppl 3):845-849
6. O'Brien MJ, Winawer SJ, Zauber AG, Gottlieb LS, Sternberg SS, Diaz B, Dickersin GR, Ewing S, Geller S, Kasimian D et al (1990) The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 98:371-379
7. Zitt M, Zitt M, Müller HM (2007) DNA methylation in colorectal cancer-impact on screening and therapy monitoring modalities? Dis Markers 23(1-2):51-71
8. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428
9. Laird PW (2003) Early detection: The power and the promise of DNA methylation markers. Nat Rev Cancer 3:253-266
10. Widschwendter M, Jones PA (2002) DNA methylation and breast carcinogenesis. Oncogene 21:5462-5482
11. Jubb AM, Bell SM, Quirke P (2001) Methylation and colorectal cancer. J Pathol 195:111-134
12. Caldwell GM, Jones C, Gensberg K, Jan S, Hardy RG, Byrd P, Chughtai S, Wallis Y, Matthews GM, Morton DG (2004) The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 64:883-888
13. Qi J, Zhu YQ, Luo J, Tao WH (2006) Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World J Gastroenterol 12:7113-7117
14. Suzuki H, Gabrielson E, Chen W, Ambazhagan R, van Engeland M, Weijenberg MP, Herman JG, Baylin SB (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31:141-149
15. Müller HM, Oberwalder M, Fiegl H, Morandell M, Goebel G, Zitt M, Mühlthaler M, Öfner D, Margreiter R, Widschwendter M (2004) Methylation changes in faecal DNA: A marker for colorectal cancer screening? Lancet 363:1283-1285
16. Petko Z, Ghiassi M, Shuber A, Gorham J, Smalley W, Washington MK, Schultenover S, Gautham S, Markowitz SD, Grady WM (2005) Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res 11:1203-1209
17. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, Melanie Ehrlich M, Laird PW (2005) Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 33(21):6823-6836
18. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW (2000) MethyLight: A high-throughput assay to measure DNA methylation. Nucleic Acids Res 28:E32
19. Müller HM, Widschwendter A, Fiegl H, Ivarson L, Goebel G, Perkmann E, Marth C, Widschwendter M (2003) DNA methylation in serum of breast cancer patients: An independent prognostic marker. Cancer Res 63:7641-7645
20. Vijan S, Inadomi J, Hayward RA, Hofer TP, Fendrick AM (2004) Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther 20:507-515
21. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME (2004) Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351:2704-2714
22. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN (2002) Screening for colorectal cancer in adults at average risk: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137:132-141
23. Ahlquist DA, Shuber AP (2002) Stool screening for colorectal cancer: evolution from occult blood to molecular markers. Clin Chim Acta 315:157-168
24. Davies RJ, Miller R, Coleman N (2005) Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer 5:199-209
25. Loktionov A, O'Neill IK, Silvester KR, Cummings JH, Middleton SJ, Miller R (1998) Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer. Clin Cancer Res 4:337-342
26. Boynton KA, Summerhayes IC, Ahlquist DA, Shuber AP (2003) DNA integrity as a potential marker for stool-based detection of colorectal cancer. Clin Chem 49:1058-1065
27. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP (1998) Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 58:5489-5494
28. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7:536-540
29. Nakagawa H, Nuovo GJ, Zervos EE, Martin EW Jr, Salovaara R, Aaltonen LA, de la Chapelle A (2001) Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res 61:6991-6995
30. Yoo CB, Jones PA (2006) Epigenetic therapy of cancer: Past, present and future. Nat Rev Drug Discov 5:37-50